AJ

Ashish Joshi

Active Director Director DIN 10864431
DIN 10864431 First appointment Dec 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2024
Shareholding value •••• Premium profile

About Ashish Joshi

Data last updated:

Ashish Joshi is a Director at Akpash Pharmaceuticals Private Limited (since 2024). The company operates in Pharma. Akpash Pharmaceuticals Private Limited reported revenue of ₹11.3 Lakh (FY 2024).

DIN 10864431
Primary Designation Director
Industry Pharma
First Appointment 19 Dec 2024
Oldest Company Age 22 yrs
Largest company Akpash Pharmaceuticals Private Limited · ₹11.3 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Dec 20242004₹11.3 Lakh (FY 2024)Active

Directorship timeline

Open interactive timeline →
Akpash Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ashish Joshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashish Joshi

Ashish Joshi currently holds 1 directorship: Akpash Pharmaceuticals Private Limited (Director, since 19 Dec 2024, revenue ₹11.3 Lakh (FY 2024)).

Ashish Joshi was first appointed on 19 Dec 2024 as Director at Akpash Pharmaceuticals Private Limited.

The current boards of Ashish Joshi's companies include Ajaj Ahmmad (Akpash Pharmaceuticals Private Limited), Ravindra Mandloi (Akpash Pharmaceuticals Private Limited), Virendra Singh Mandloi (Akpash Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available